Stockreport

PainReform Announces Initial Topline Data for PRF-110 Phase 3 Clinical Trial

PainReform Ltd. - Ordinary Shares  (PRFX) 
PDF TEL AVIV, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company f [Read more]